Jinrong Zhou Verified

Pharmaceutical Compliance and Regulatory Defense in Beijing

Jinrong Zhou advises pharmaceutical and biotechnology companies, medical device manufacturers, hospitals and distributors on regulatory compliance, product lifecycle obligations and dispute resolution from Beijing.

Ms. Zhou holds a law degree with clinical medicine background and practices at a Beijing law firm. She was admitted in 2013 and has about thirteen years of professional experience, working in English and Mandarin with Beijing Bar Association credentials on file.

Drug and device files are multi-regulator and multi-contract. Registration classifications, advertising claims, promotional materials, labelling and distribution agreements must align. Global HQ templates that ignore China-specific pathways create launch delays and inspection risk.

Advertising, KOL Promotion and Off-Label Risk

She reviews customer-facing materials, training decks and KOL engagement plans before they reach the field, with a focus on claims control, approved-label consistency and off-label promotion exposure.

Pharmaceutical advertising and medical representative conduct are recurring enforcement themes. Claim language that works in English marketing often oversteps Chinese standards. She pre-clears materials and builds internal approval workflows that leave an audit trail.

Adverse event and recall communications are sequenced with insurer and distributor notice duties so messages stay consistent across channels.

Medical Device and Product Liability

When products are detained, delisted or disputed under supply contracts, she builds enforcement and settlement strategies with bilingual summaries for overseas manufacturers.

Product liability and recall matters require early evidence planning. She secures samples, packaging records, lot traceability and complaint history, and coordinates expert appraisal questions that separate product performance from clinical factors.

Parallel IP and unfair-competition issues are coordinated rather than siloed. Regulatory investigations are handled with a privilege-aware plan that preserves internal analysis while keeping safety reporting clocks moving.

How to Engage

Provide product type, current registration status, target launch timing and any inspection or complaint notice already received. Scope is confirmed in writing through this profile's inquiry channel.